420 with CNW – What Women Should Know About Marijuana and Breast Cancer

Breast Cancer Awareness is held in the month of October. Chances are, you know someone who has been diagnosed with breast cancer. According to U.S. breast cancer statistics, there is a probability that one in eight women in America will develop breast cancer over their lifetime.

The Centers for Disease Control and Prevention states that not factoring in other types of cancers, the most common type of cancer among women in the U.S is breast cancer. It does not discriminate on race or ethnicity, and anyone can develop breast cancer.

Women can now use marijuana to manage the side effects and pain caused by breast cancer treatment. Listed below are the benefits of using medical marijuana for breast cancer:

• Eases pain by reducing inflammation.
• Manages chemotherapy side effects such as nausea and vomiting.
• Stimulates appetite suppressed by rounds of chemotherapy.
• Relieves anxiety.
• Induces relaxation thus stimulating sleep.
• It inhibits the growth of cancer cells and reduces the size of the tumor.

It is essential to understand that women and men's health differ; therefore, the medical community has tried to develop treatment tailored to meet the needs of each individual instead of thinking one size fits all.

Cannabinoid receptors in women are sensitive, especially those located in the uterus, and since they are concentrated, they help in relieving pain, regulating mood, improving appetite, and inducing sleep more effectively than in men. Also, women require lower doses of marijuana because the presence of cannabinoid receptors enables their bodies to absorb marijuana quickly and efficiently. This provides them with better pain relief and management of other symptoms they may experience.

The regular use of marijuana can lead to marijuana tolerance, and this would require women to up their dosage over time.

The menstrual cycle causes estrogen levels to fluctuate, which makes women more sensitive to the effects of marijuana. Therefore, they should adjust the doses according to the level of the estrogen to achieve the desired impact. For example, lower doses should be taken around ovulation when estrogen is highest.

Hormonal therapy is prescribed for women to slow the growth and spread of breast cancer cells. This therapy can either add or remove hormones, which eventually affects the body's response to marijuana. A recent study on cannabis that used animal subjects shows that CBD, one of the compounds found in marijuana, helps to shrink breast cancer cells and reduce tumor growth.

Experts think that different groups of patients need specialized information to help them understand how medical marijuana can be of help to them, and that could be the reason why marijuana companies like VIVO Cannabis Inc. (TSX.V: VIVO) VVCIF and Organigram Holdings Inc. OGI OGI emphasize the provision of information so that customers make informed decisions when selecting products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.